These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34287992)

  • 1. Rezūm for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia.
    Bassily D; Wong V; Phillips JL; Fraiman M; Bauer R; Dixon CM; Wong NC
    Prostate; 2021 Oct; 81(14):1049-1054. PubMed ID: 34287992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world evidence with The Rezūm System: A retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes.
    Ines M; Babar M; Singh S; Iqbal N; Ciatto M
    Prostate; 2021 Sep; 81(13):956-970. PubMed ID: 34254333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rezŭm water vaporization therapy versus transurethral resection of the prostate in the management of refractory urine retention: matched pair comparative multicenter experience.
    Tayeb W; Azhar RA; Subahi M; Munshi S; Qarni A; Bakhsh A; Sejiny M; Almohaisen T; Alammari A; Elkoushy MA
    World J Urol; 2024 Jan; 42(1):48. PubMed ID: 38244100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review.
    Babar M; Loloi J; Tang K; Syed U; Ciatto M
    Low Urin Tract Symptoms; 2022 May; 14(3):140-154. PubMed ID: 35233955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rezum Therapy for Benign Prostatic Hyperplasia: Dubai's Initial Experience.
    Rowaiee R; Akhras A; Lakshmanan J; Sikafi Z; Janahi F
    Cureus; 2021 Sep; 13(9):e18083. PubMed ID: 34692298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
    Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic Artery Embolization in Nonindex Benign Prostatic Hyperplasia Patients: Single-center Outcomes for Urinary Retention and Gross Prostatic Hematuria.
    Ayyagari R; Powell T; Staib L; Chapiro J; Perez-Lozada JC; Bhatia S; Chai T; Schoenberger S; Devito R
    Urology; 2020 Feb; 136():212-217. PubMed ID: 31734349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis.
    Haroon UM; Khan JS; McNicholas D; Forde JC; Davis NF; Power RE
    Ir J Med Sci; 2022 Feb; 191(1):421-426. PubMed ID: 33599918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rezūm water vapor therapy for the treatment of patients with urinary retention and permanent catheter dependence secondary to benign prostate hyperplasia: a systematic review of the literature.
    Spinos T; Katafigiotis I; Leotsakos I; Grivas N; Zabaftis C; Ermidis D; Sfoungaristos S; Karavitakis M
    World J Urol; 2023 Feb; 41(2):413-420. PubMed ID: 36534152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year follow-up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study.
    Samir M; Elaal AAA; Gad KAS; Basyony MW
    Int J Urol; 2024 May; 31(5):545-550. PubMed ID: 38291876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
    Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: A retrospective single-centre analysis from a German high-volume centre.
    Winkler T; von Klot CAJ; Madersbacher S; Kuczyk MA; Wolters M
    PLoS One; 2023; 18(1):e0279883. PubMed ID: 36607843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Study of "Less is More" Rezum for Treatment of BPH.
    Aladesuru O; Amankwah K; Elterman D; Zorn KC; Bhojani N; Te A; Chughtai B
    Urology; 2022 Jul; 165():256-260. PubMed ID: 35139413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.
    Elterman D; Shepherd S; Saadat SH; Alshak MN; Bhojani N; Zorn KC; Rijo E; Misrai V; Lajkosz K; Chughtai B
    Can J Urol; 2021 Oct; 28(5):10824-10833. PubMed ID: 34657655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study.
    Siena G; Cindolo L; Ferrari G; Maruzzi D; Fasolis G; Condorelli SV; Varvello F; Visalli F; Rabito S; Toso S; Caroassai S; Mari A; Viola L; Somani BK; Carini M
    World J Urol; 2021 Oct; 39(10):3875-3880. PubMed ID: 33787986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of the Rezum system for the treatment of catheter-dependent urinary retention: Three-year real-world outcomes in a multimorbid, multiethnic population.
    Babar M; Masoud Z; Labagnara K; Loloi J; Sayed R; Singh S; Tang K; Syed U; Ciatto M
    Low Urin Tract Symptoms; 2023 Jul; 15(4):148-153. PubMed ID: 37190924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
    Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Rezum therapy as a minimally invasive modality for management of Benign Prostatic Hyperplasia: A prospective observational study.
    Abouelgreed TA; Koritenah AK; Badran Y; Tagreda I; Algammal M; Abozied H; Eldamanhory HA; Shouman HA; Khattab AA; Ali M; Alnajem MT; Abdelwahed AA
    Arch Ital Urol Androl; 2023 Dec; 95(4):12026. PubMed ID: 38193224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rezūm water vapor thermal therapy in patients with benign prostatic hyperplasia: Initial real-world data from Japan.
    Obinata D; Mochida J; Uehara R; Osawa M; Hashimoto S; Nakahara K; Yoshizawa T; Yamaguchi K; Takahashi S
    Medicine (Baltimore); 2023 Nov; 102(46):e36055. PubMed ID: 37986385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.